An Orange County Superior Court judge has ordered California’s Department of Cannabis Control to take steps to bring the state’s cannabis track-and-trace system into compliance with California law, concluding that the system does not currently flag irregular transactions for investigation. The August 4, 2026, final judgment [...]

Cannabis brands often approve a cartridge sample and then place a production order based solely on the product description. That shortcut leaves the filling partner, packaging team, and vape supplier to resolve important details after the purchase order has been submitted. A “controlled specification packet” must [...]

Cannabis federal reform has finally reached a historic moment. Medical cannabis is moving through the rescheduling process after decades under federal prohibition, marking one of the biggest developments in the industry’s history. The final outcome could determine how companies expand, whether cannabis can move across state [...]

New research from Abstrax suggests that extraction temperature may be one of the most important process controls for producing cleaner hydrocarbon cannabis extracts. The peer-reviewed study found that colder butane extraction significantly reduced the levels of wax-derived hydrocarbons in the final concentrate while preserving cannabinoids and [...]

The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based supplements and medicines backed by more rigorous scientific research. For some companies, this isn’t a new direction. It’s the payoff from years of work [...]

Pre-roll complaints do not always show up the way other product issues do. A failed device may come back to the store. A vape problem may create a clearer return path. A broken package or hardware issue is easier to document. Pre-rolls are different. They are [...]

Technology is a major expense for cannabis businesses today. But with shrinking margins and heavy competition, operators cannot afford to waste money on software that doesn’t perform. The big question for leadership is no longer about adopting technology; it is about ensuring that technology solves real [...]

Yesterday, the Pennsylvania Senate rejected SB 49, Sen. Dan Laughlin’s Cannabis Control Board bill, on a 27-23 floor vote. Then, within the same session, lawmakers filed a motion to reconsider, and it passed 29-21. The bill lives, for now, in a kind of legislative purgatory. If [...]

“Everybody who came here today, and not giving up and saying that we’re going to continue to fight for this category, thank you, give yourself a round of applause, please,” were the fighting words of Christopher Lackner, President of the Hemp Beverage Alliance (HBA), as he [...]

On April 22, 2026, Acting Attorney General Todd Blanche signed an order placing state-licensed medical marijuana into Schedule III of the Controlled Substances Act. The cannabis industry declared it a turning point. In certain respects, it is. But turning points are not endpoints. And for California [...]

For much of the cannabinoid supply market, the model has been simple: make the molecule, test the batch, sell the material. If the product meets basic specifications, passes third-party testing, and can be produced at a competitive price, it is considered ready for market. That model [...]

For years, cannabis operators have accepted labeling inefficiencies as an unavoidable cost of doing business. Yet, many facilities still rely on fragmented, manual workflows that require employees to export spreadsheets, copy cannabinoid results, and rekey intricate terpene data into static label templates. This traditional approach actively [...]

Every conversation about cannabis risk follows the same script: Regulatory uncertainty, 280E, capital access, and maybe interstate commerce, depending on the room. None of that is wrong, and operators dealing with those pressures daily don’t need me to tell them they’re real. But after more than [...]

LeafLink’s Wholesale Cannabis Pricing Guide, drawing on over 400,000 SKUs and billions of dollars in transaction data across 18 U.S. markets throughout 2025, paints a picture of the wholesale cannabis pricing continuing its downward march as markets mature and supply expands — with each market and [...]

The April 2026 Department of Justice rescheduling order landed with the weight of a decade of advocacy behind it. For an industry that has watched every other legal sector deduct its rent, payroll, and marketing costs while cannabis operators paid taxes on money they never made, [...]

Pre-rolls generated $4 billion in sales in 2025 and are projected to grow faster than any other top cannabis category, at a 10% compound annual growth rate, according to BDSA retail tracking data. Infused formats now account for 43% of the segment, and the category has [...]

SOCi’s 2026 Local Visibility Index analyzed more than 350,000 business locations across 2,751 brands and found a gap every dispensary operator should take seriously. ChatGPT recommends 1.2% of those locations. Perplexity recommends 7.4%. Gemini reaches 11%. Google’s local 3-pack surfaces 35.9% of the same locations. That [...]

Packing is meant to provide protection and preservation for the contents, but some products require an additional layer of safety. Just like cannabis related products, they can’t be packed in unreliable packaging that poses the risk of degradation of the quality. In this article, we’ll explore [...]

Choosing between glass and plastic packaging for cannabis concentrates is a strategic decision with downstream consequences for product integrity, compliance, consumer perception, margins, and brand positioning. This article compares the two materials across five dimensions and offers a decision framework for operators to match packaging to [...]

Cannabis cultivation is, at its core, a controlled environment business, and air quality remains one of the most consistently underestimated variables in the operation. Contaminated batches, worker health complaints, and odor violations affecting neighboring communities can all be traced back to air-handling decisions made early in [...]

Most cannabis operators have a banking problem. For many, that means limited access to financial services, forcing the business to operate largely in cash and be unable to use the standard banking rails every other industry takes for granted. The banking conversation in this industry almost [...]

Legalization has been framed as a turning point for cannabis safety, transparency, and adoption for years, but now, over a decade since recreational cannabis sales began, American consumers are taking a closer look and asking tougher questions about whether the industry is living up to that [...]

As U.S. cannabis rescheduling moves forward and export opportunities to the European Union become available, a new certification tool to help producers prove their products meet EU standards and fight back against supply chain fraud is now available. CSQ (Cannabis Safety & Quality), the first ANAB-accredited [...]

The U.S. cannabis industry generated more than $30 billion in regulated sales in 2025, yet profitability has become harder to predict. According to a recent national index report by Cannabis Benchmarks, wholesale pricing remains volatile, recently fluctuating between approximately $987 and $1,007 per pound. In an [...]

As cannabis becomes a globally traded medical commodity, cGMP compliance is reshaping how it is grown, handled, and transported. For operators working with imported biomass, controlling contamination and ensuring consistency across supply chains has become a defining challenge. That challenge was a central focus at the [...]

Picture the moment a cannabis company’s compliance team gets copied on an email from a banking partner’s risk officer. The subject line says “Questions re: public materials.” Attached is a spreadsheet. On one side, language from the company’s Florida medical dispensary website. On the other, language [...]

Cannabis packaging decisions have downstream consequences for compliance, operations, customer perception, and margins. This article offers a practical framework for evaluating packaging suppliers across five dimensions: compliance, product quality, operational fit, customization, and partnership reliability. It closes with a pre-commitment checklist that operators can use before [...]

Driven by innovation and convenience, pre-roll sales in 2025 not only had the strongest growth of any major category, topping $3.6 billion in sales and moving 383 million units, but supplanted flower as the most units sold for the first time in the industry’s history, according [...]

As federal policymakers move toward restricting hemp-derived cannabinoid products, a new state-level effort in Colorado is taking the opposite approach by moving to integrate low-dose THC beverages into mainstream hospitality. A coalition led by Colorado-based attorney Brian Vicente, partner at Vicente LLP, has formed the Colorado [...]

As the U.S. hemp industry braces for potential federal disruption later this year, a new bipartisan bill aims to give states a way to maintain control over intoxicating hemp products and potentially keep the category alive. Sens. Rand Paul (R-KY), Amy Klobuchar (D-MN), and Joni Ernst [...]

For years, the cannabis industry operated in an environment where expansion was the primary signal of success, and investors were excited to get involved. New markets opened, and rapid growth often took priority over efficiency. Companies could move quickly and sort out the details later, trusting [...]

In 2024, Colorado state officials announced a recall affecting 172 stores across the state. Batches of flower and pre-rolled joints from one grower exceeded mold and yeast limits. The losses were immense, including for companies that thought the money they were paying each year to insurance [...]

A cannabis biopharma company is seeking to join the federal lawsuit challenging the Centers for Medicare & Medicaid Services’ (CMS) new hemp and CBD pilot program, adding a pharmaceutical voice to a government-sanctioned program allowing untested and unregulated hemp products into the marketplace. MMJ International Holdings [...]

All roads in cannabis retail lead back to inventory. Retail cannabis operators across the country are being squeezed by razor-thin margins, declining cash flow, and a growing inability to pay vendors on time. The culprit is often not weak sales or lack of demand. It is [...]

Press release first published by Congressman Troy Carter (D-LA): WASHINGTON, D.C. – Congressman Troy A. Carter, Sr. (D-LA) and Congressman Guy Reschenthaler (R-PA) have introduced the bipartisan Capital Lending and Investment for Marijuana Businesses (CLIMB) Act. This legislation will allow state-legal American cannabis companies, including small, minority, and [...]

For many cannabis founders, the exit problem is not finding the right buyer. It is that there are barely any buyers at all. The field is narrow, capital is tight, and the strategic buyers that do exist are rarely showing up with clean cash offers. More [...]

It starts with a routine test result. A mid-size cannabis brand discovers that a batch of infused edibles has failed a pesticide screening. Within 48 hours, the company issues a voluntary recall, pulls product from dozens of dispensary shelves, and begins fielding calls from anxious retail [...]

Missouri has quietly built one of the country’s more successful adult-use cannabis markets since launching recreational sales in 2023. Since legalization, the state has quickly grown into one of the largest cannabis markets in the Midwest, generating strong sales and supporting an expanding network of cultivators, [...]

While the cannabis industry has made significant strides in incorporating minor cannabinoids into product formulations, a vast number of therapeutic compounds remain largely unexplored. Researchers and cannabis physicians have been experimenting with acidic cannabinoids for several years with promising results, but the broader industry is only [...]

Biotechnology, cannabis medicine, and the rapid advancements in artificial intelligence (AI) and machine learning (ML) are beginning to converge. Hemant Kumar Bid, program director for the Master of Science in Biotechnology and the Medical Cannabis concentration at Morehouse School of Medicine, believes this convergence could dramatically [...]

When most people think of luxury goods, they picture high-quality, high-priced products. But what truly sets luxury apart is not just cost. It is craftsmanship, design, heritage, cultural cachet, and mastery of materials and technique. Luxury is a sensory experience rooted in both tradition and innovation. [...]

There’s an opportunity in the pre-roll sector that many companies are missing. The pre-roll sector is the fastest-growing category in the cannabis industry. In 2025 alone, $3.6 billion worth of pre-rolls were sold across the 14 markets tracked by cannabis analytics firm Headset. Customers love the [...]

Maryland launched its medical cannabis program in 2018 and transitioned to adult use in 2024 as a limited-license state. Currently, there are 108 active dispensaries, with additional operators expected to come online following a March 2024 lottery that awarded conditional licenses to social equity entrepreneurs. However, [...]

A new scientific review published in the National Library of Medicine (NIH) shines a spotlight on one of the most overlooked areas of cannabis science: the untapped benefits of acidic cannabinoids naturally produced by Cannabis sativa — THCA, CBDA, CBGA, and CBCA. These compounds are the [...]

2025 saw most businesses scrutinizing their operations to trim margins and survive the tumultuous market. 2026 is about digging deeper to uncover hidden costs that will further improve their bottom line.   Tom Zuber, partner at Zuber Lawler, led a panel discussion at the recent IgniteNJ event, [...]